Namara Marketplace
Request data
Top 100 prescribed drugs in Canada by Total Program Spending and Income
|
Sort Code
Want total control?Request access to start using the data. |
Jurisdiction
Want total control?Request access to start using the data. |
Jurisdiction Code
Want total control?Request access to start using the data. |
Geography
Want total control?Request access to start using the data. |
Drug Class Code
Want total control?Request access to start using the data. |
Drug Class
Want total control?Request access to start using the data. |
Tps In Thousands Of Dollars
Want total control?Request access to start using the data. |
Proportion Of Tpspercent
Want total control?Request access to start using the data. |
Rate Of Usepercent
Want total control?Request access to start using the data. |
Number Of Active Beneficiaries
Want total control?Request access to start using the data. |
Tps Rank
Want total control?Request access to start using the data. |
|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
J05AP
|
Antivirals for treatment of HCV infections
|
193552.3781
|
7.5445
|
0.1758
|
3723
|
1
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
L04AB
|
Tumour necrosis factor alpha (TNF-a) inhibitors
|
162705.75633
|
6.3422
|
0.399
|
8451
|
2
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
S01LA
|
Antineovascularization agents
|
120249.05318999999
|
4.6872
|
0.6067
|
12851
|
3
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N05AX
|
Other antipsychotics
|
86016.40517
|
3.3529
|
3.0184
|
63938
|
4
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
L01XE
|
Protein kinase inhibitors
|
64810.82767
|
2.5263
|
0.0852
|
1805
|
5
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
R03AK
|
Adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics
|
64655.32157
|
2.5202
|
5.0197
|
106331
|
6
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
B01AF
|
Direct factor Xa inhibitors
|
63460.794259999995
|
2.4737
|
3.5768
|
75767
|
7
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N07BC
|
Drugs used in opioid dependence
|
60500.19593
|
2.3583
|
1.545
|
32728
|
8
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
J05AR
|
Antivirals for treatment of HIV infections, combinations
|
57757.3408
|
2.2513
|
0.2986
|
6326
|
9
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
L04AA
|
Selective immunosuppressants
|
51689.78808
|
2.0148
|
0.4012
|
8498
|
10
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
A10AE
|
Insulins and analogues for injection, long-acting
|
51590.67626
|
2.011
|
2.9565
|
62628
|
11
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
L04AX
|
Other immunosuppressants
|
48385.77882
|
1.886
|
0.2892
|
6127
|
12
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
A10BH
|
Dipeptidyl peptidase-4 (DPP-4) inhibitors
|
48266.46474
|
1.8814
|
2.5276
|
53542
|
13
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N06AX
|
Other antidepressants
|
48121.77937
|
1.8758
|
11.3411
|
240238
|
14
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
A10BD
|
Combinations of oral blood glucose–lowering drugs
|
47798.33868
|
1.8631
|
2.3795
|
50404
|
15
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
C10AA
|
HMG-CoA reductase inhibitors
|
47697.17356
|
1.8592
|
25.8633
|
547860
|
16
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N02AA
|
Natural opium alkaloids
|
41438.44769
|
1.6152
|
5.1728
|
109575
|
17
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
A02BC
|
Proton pump inhibitors
|
40792.358909999995
|
1.5901
|
19.3139
|
409125
|
18
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
A10BK
|
Sodium–glucose co-transporter 2 (SGLT2) inhibitors
|
40208.975880000005
|
1.5673
|
2.4785
|
52502
|
19
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N03AX
|
Other antiepileptics
|
38323.40909
|
1.4938
|
8.0726
|
171001
|
20
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N05AH
|
Diazepines, oxazepines, thiazepines and oxepines
|
37493.47807
|
1.4615
|
4.9564
|
104992
|
21
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N06AB
|
Selective serotonin reuptake inhibitors
|
36939.77934
|
1.4399
|
12.1216
|
256770
|
22
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
L04AC
|
Interleukin inhibitors
|
29210.227460000002
|
1.1386
|
0.0944
|
2000
|
23
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
R03BB
|
Anticholinergics
|
27953.89918
|
1.0896
|
4.0725
|
86267
|
24
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
C08CA
|
Dihydropyridine derivatives
|
26704.215239999998
|
1.0409
|
12.4231
|
263158
|
25
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
C09AA
|
ACE inhibitors, plain
|
25001.06838
|
0.9745
|
14.3358
|
303675
|
26
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N06BA
|
Centrally acting sympathomimetics
|
23371.547420000003
|
0.911
|
2.131
|
45140
|
27
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
M05BX
|
Other drugs affecting bone structure and mineralization
|
20095.35993
|
0.7833
|
1.3474
|
28542
|
28
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
C09CA
|
Angiotensin II receptor blockers (ARBs), plain
|
20039.29619
|
0.7811
|
8.3334
|
176525
|
29
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
R03BA
|
Glucocorticoids
|
19379.125780000002
|
0.7554
|
5.8905
|
124779
|
30
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
A10AB
|
Insulins and analogues for injection, fast-acting
|
19249.96501
|
0.7504
|
1.9268
|
40816
|
31
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
C07AB
|
Beta-blocking agents, selective
|
17947.31018
|
0.6996
|
11.7423
|
248737
|
32
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
H03AA
|
Thyroid hormones
|
15281.762429999999
|
0.5957
|
10.4652
|
221683
|
33
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
M05BA
|
Bisphosphonates
|
14664.53556
|
0.5716
|
3.1831
|
67427
|
34
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N02AJ
|
Opioids in combination with non-opioid analgesics
|
14423.60141
|
0.5622
|
11.2909
|
239175
|
35
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
G04BD
|
Drugs for urinary frequency and incontinence
|
14034.40187
|
0.5471
|
2.1162
|
44827
|
36
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
B01AC
|
Platelet aggregation inhibitors, excluding heparin
|
13765.57286
|
0.5366
|
2.7162
|
57537
|
37
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
L02AE
|
Gonadotropin-releasing hormone analogues
|
13299.7151
|
0.5184
|
0.2012
|
4263
|
38
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
V06DB
|
Fats/carbohydrates/proteins/minerals/vitamins, combinations
|
11823.580759999999
|
0.4609
|
0.3732
|
7905
|
39
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
M03AX
|
Other muscle relaxants, peripherally acting agents
|
11499.03142
|
0.4482
|
0.2334
|
4945
|
40
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
A10BA
|
Biguanides
|
11471.912859999999
|
0.4472
|
9.453
|
200243
|
41
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
R03AC
|
Selective beta-2-adrenoreceptor agonists
|
11449.82388
|
0.4463
|
14.8336
|
314220
|
42
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
G04CA
|
Alpha-adrenoreceptor antagonists
|
11246.06461
|
0.4384
|
4.6144
|
97747
|
43
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
R03DX
|
Other systemic drugs for obstructive airway diseases
|
11161.848779999998
|
0.4351
|
0.0325
|
689
|
44
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
R03AL
|
Adrenergics in combination with anticholinergics, including triple combinations with corticosteroids
|
11103.16094
|
0.4328
|
1.1736
|
24861
|
45
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
L03AA
|
Colony-stimulating factors
|
10932.689880000002
|
0.4261
|
0.1066
|
2259
|
46
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
L04AD
|
Calcineurin inhibitors
|
10642.894699999999
|
0.4149
|
0.144
|
3051
|
47
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
B01AB
|
Heparin group
|
10343.99874
|
0.4032
|
0.3687
|
7810
|
48
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
S01EE
|
Prostaglandin analogues
|
10153.40404
|
0.3958
|
2.196
|
46517
|
49
|
|
1
|
Canada
|
Can.
|
Neighbourhood income: Q1 (lowest)
|
N05BA
|
Benzodiazepine derivatives
|
10061.49567
|
0.3922
|
7.1195
|
150811
|
50
|
Want to start using the data?
Namara offers a connection to over 250K data feeds from every industry and the tools to drive value and insight.